145 related articles for article (PubMed ID: 33761530)
1. Challenging Topics in Pancreatic Neoplasia.
Basturk O; Krasinskas AM
Arch Pathol Lab Med; 2020 Jul; 144(7):806-807. PubMed ID: 33761530
[No Abstract] [Full Text] [Related]
2. [Mixed ductal endocrine carcinoma of the pancreas].
Zehani A; Chelly I; Azouz H; Makni A; Haouet S; Kchir N
Ann Pathol; 2012 Aug; 32(4):296-8. PubMed ID: 23010408
[No Abstract] [Full Text] [Related]
3. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic Neuroendocrine Neoplasms: Landscape and Horizon.
Tang LH
Arch Pathol Lab Med; 2020 Jul; 144(7):816-828. PubMed ID: 32298138
[TBL] [Abstract][Full Text] [Related]
5. EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma.
Park SJ; Gu MJ; Lee DS; Yun SS; Kim HJ; Choi JH
Int J Clin Exp Pathol; 2015; 8(7):8298-304. PubMed ID: 26339400
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysis.
Gao HL; Liu L; Qi ZH; Xu HX; Wang WQ; Wu CT; Zhang SR; Xu JZ; Ni QX; Yu XJ
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):95-100. PubMed ID: 29576277
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology.
McHugh KE; Stelow EB; Harrison GP; Policarpio-Nicolas MLC
Cancer Cytopathol; 2019 Nov; 127(11):700-707. PubMed ID: 31584754
[TBL] [Abstract][Full Text] [Related]
8. Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?
Hijioka S; Hosoda W; Mizuno N; Hara K; Imaoka H; Bhatia V; Mekky MA; Tajika M; Tanaka T; Ishihara M; Yogi T; Tsutumi H; Fujiyoshi T; Sato T; Hieda N; Yoshida T; Okuno N; Shimizu Y; Yatabe Y; Niwa Y; Yamao K
J Gastroenterol; 2015 May; 50(5):564-72. PubMed ID: 25142799
[TBL] [Abstract][Full Text] [Related]
9. Poorly differentiated endocrine carcinoma and intraductal papillary-mucinous neoplasm of the pancreas: Description of an unusual case.
Stukavec J; Jirasek T; Mandys V; Denemark L; Havluj L; Sosna B; Kosmahl M; Zadorova Z
Pathol Res Pract; 2007; 203(12):879-84. PubMed ID: 17936521
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of IQGAP1 in human pancreatic cancer.
Wang XX; Li XZ; Zhai LQ; Liu ZR; Chen XJ; Pei Y
Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):540-5. PubMed ID: 24103286
[TBL] [Abstract][Full Text] [Related]
11. Genomics of pancreatic ductal adenocarcinoma.
Pilarsky C; Grutzmann R
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):381-5. PubMed ID: 25100122
[TBL] [Abstract][Full Text] [Related]
12. African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression.
Jones J; Mukherjee A; Karanam B; Davis M; Jaynes J; Reams RR; Dean-Colomb W; Yates C
Cancer Lett; 2016 Oct; 380(2):513-522. PubMed ID: 27424525
[TBL] [Abstract][Full Text] [Related]
13. Lipocalin-2 Expression in Pancreas Adenocarcinoma Tumor Microenvironment Via Endoscopic Ultrasound Fine Needle Biopsy Is Feasible and May Reveal a Therapeutic Target.
Gleeson FC; Levy MJ; Jackson RA; Murphy SJ; Halling KC; Kipp BR; Graham RP; Zhang L
Pancreas; 2020; 49(10):e98-e99. PubMed ID: 33122534
[No Abstract] [Full Text] [Related]
14. Understanding genetic features of pancreatic neoplasm.
He J; Zhang ZG; Yu X
Chin Clin Oncol; 2019 Apr; 8(2):15. PubMed ID: 31070036
[No Abstract] [Full Text] [Related]
15. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
16. AGA Clinical Practice Update on Colorectal and Pancreatic Cancer Risk and Screening in BRCA1 and BRCA2 Carriers: Commentary.
Kupfer SS; Gupta S; Weitzel JN; Samadder J
Gastroenterology; 2020 Aug; 159(2):760-764. PubMed ID: 32335146
[No Abstract] [Full Text] [Related]
17. Protein biomarker for pancreatic ductal adenocarcinoma.
Burki T
Lancet Oncol; 2017 Sep; 18(9):e511. PubMed ID: 28736187
[No Abstract] [Full Text] [Related]
18. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of NUMB, APP and VEGFA as the features of pancreatic ductal carcinoma.
Zheng KL; He TL; Ji WP; Jiang H; Shen Y; Li G; Zhu SB; Tong BL; Zhang YJ
Int J Clin Exp Pathol; 2015; 8(6):6181-91. PubMed ID: 26261495
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options.
Semaan A; Maitra A
Nat Rev Gastroenterol Hepatol; 2018 Feb; 15(2):76-78. PubMed ID: 29317774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
